Digital health company, NeurodigitX reported on Wednesday the launch of Plastic Health platform, which allows a powerful mainstream bloodless assessment of inflammation levels in the current COVID-19 pandemic to enhance vaccine immunization strategies.
The company reportedly collects HRV, respiratory and cognitive data with the Plastic Egg, a biosensor and breathing-based game controller and Plastic mobile games guiding user's breath to measure inflammation accurately. Repeated gameplay allows profiling of slowly evolving (stress, chronic disease) and rapid changes (virus exposure, immunization) in inflammation status.
According to the company, it provides the only protocol-controlled, high-resolution, longitudinal, individualized routine measure of HRV and brain plasticity to closely track inflammation status. The Plastic Health reveals a draining of plasticity reserve, reflecting inflammation changes.
Nearly 50,000 scientific studies have been released on HRV (Heart Rate Variability), which affords a noninvasive assessment of inflammation of brain and bodily function. The company's Plastic Health combines individualized assessment and the heatmapping of public health. COVID-19 infection shows sudden inflammation change, further altered by the negative impact of cumulative stress.
BenevolentAI reports positive Phase Ia safety and pharmacokinetic data for BEN-8744
Thermo Fisher Scientific unveils CorEvitas registry for generalized pustular psoriasis
Nektar Therapeutics commences Phase 2b rezpegaldesleukin clinical trial for alopecia areata
Innovent Biologics doses first participant in first-in-human phase one clinical trial of IBI3002
Ananda Developments secures CBD Drug Supply Agreement for endometriosis clinical trial
Trellus Health secures agreement with major US health plan for IBD management
Chemomab secures new patents for CM-101 monoclonal antibody
argenx receives FDA priority review for VYVGART Hytrulo in CIDP